Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer. (Record no. 19219557)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02468 a2200661 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515191535.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201001s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1527-7755 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1200/JCO.2009.23.2777 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Matulonis, Ursula A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20100105 |
245 00 - TITLE STATEMENT | |
Title | Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
Date of publication, distribution, etc. | Nov 2009 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 5601-6 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Administration, Oral |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dose-Response Relationship, Drug |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Administration Schedule |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fallopian Tube Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Maximum Tolerated Dose |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Recurrence, Local |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasms, Glandular and Epithelial |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ovarian Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Peritoneal Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prognosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Quinazolines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptors, Vascular Endothelial Growth Factor |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Assessment |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Berlin, Suzanne |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ivy, Percy |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tyburski, Karin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Krasner, Carolyn |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zarwan, Corrine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Berkenblit, Anna |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Campos, Susana |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Horowitz, Neil |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cannistra, Stephen A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lee, Hang |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lee, Julie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Roche, Maria |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hill, Margaret |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Whalen, Christin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sullivan, Laura |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tran, Chau |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Humphreys, Benjamin D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Penson, Richard T |
773 0# - HOST ITEM ENTRY | |
Title | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
Related parts | vol. 27 |
-- | no. 33 |
-- | p. 5601-6 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1200/JCO.2009.23.2777">https://doi.org/10.1200/JCO.2009.23.2777</a> |
Public note | Available from publisher's website |
No items available.